Imaging studies and APOE genotype in persons at risk for Alzheimer's disease

被引：26

作者：

Scarmeas N. ^{[1
]}

Stern Y. ^{[1
]}

机构：

[1] Columbia University Medical Center, New York, NY 10032

来源：

Current Psychiatry Reports | 2006年 / 8卷 / 1期

关键词：

Mild Cognitive Impairment; Alzheimer Disease; Magnetic Resonance Imaging Study; Hippocampal Volume; APOE Genotype;

D O I：

10.1007/s11920-006-0076-1

中图分类号：

学科分类号：

摘要：

Many studies have investigated APOE-related differences in cerebral structure, blood flow, metabolism, and activation in an attempt to detect early brain changes in subjects at risk for Alzheimer's disease (AD). Structural magnetic resonance imaging studies have produced conflicting results, with some failing to detect APOE-related differences and others suggesting that ε4 carriers have more pronounced atrophy, particularly at medial temporal structures. All functional imaging studies done during rest in middle-aged and elderly subjects have found decreased cerebral metabolism for ε4 carriers (mostly in areas that usually are affected by AD), and some have reported faster cerebral metabolic reductions over time. Areas with decreased resting cerebral perfusion and metabolism, in addition to other areas with increased perfusion, have been reported in young ε4 carriers. Imaging studies done during the performance of various cognitive tasks in middle-aged and elderly subjects, and a single study in young subjects, have produced mixed results with regionally nonspecific increased, decreased, or nondifferential APOE-related activations depending on the cognitive task used. APOE-related findings in imaging studies of nondemented subjects may be the result of incipient AD pathologic changes or of genetic heterogeneity in brain structure and function. Copyright © 2006 by Current Science Inc.

引用

页码：11 / 17

页数：6

共 61 条

[1]

Corder E.H., Saunders A.M., Strittmatter W.J., Et al., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, pp. 921-923, (1993)

[2]

Saunders A.M., Strittmatter W.J., Schmechel D., Et al., Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease, Neurology, 43, pp. 1467-1472, (1993)

[3]

Alzheimer's Disease Collaborative Group: Apolipoprotein E genotype and Alzheimer's disease, Lancet, 342, pp. 737-738, (1993)

[4]

Corder E.H., Saunders A.M., Risch N.J., Et al., Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease, Nat Genet, 7, pp. 180-184, (1994)

[5]

Scarmeas N., Brandt J., Albert M., Et al., Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease, Neurology, 58, pp. 1182-1188, (2002)

[6]

Jack Jr. C.R., Petersen R.C., Xu Y.C., Et al., Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease, Ann Neurol, 43, pp. 303-310, (1998)

[7]

Killiany R.J., Hyman B.T., Gomez-Isla T., Et al., MRI measures of entorhinal cortex vs hippocampus in preclinicai AD, Neurology, 58, pp. 1188-1196, (2002)

[8]

Moffat S.D., Szekely C.A., Zonderman A.B., Et al., Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype, Neurology, 55, pp. 134-136, (2000)

[9]

Alexander G.E., Chen K., Reiman E.M., Et al., APOE e4 dose effect on gray matter atrophy in cognitively normal adults, Society for Neuroscience Conference, (2003)

[10]

Soininen H., Partanen K., Pitkanen A., Et al., Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele, Neurology, 45, pp. 391-392, (1995)

← 1 2 3 4 5 6 7 →